United Therapeutics has high revenue growth and low debt. Read why UTHR stock is undervalued with solid financial metrics and ...

The field of gene editing recently got a major boost from Massachusetts-based Beam Therapeutics, and the company’s Durham ...

United Therapeutics Co. has a fifty-two week low of $221.53 and a fifty-two week high of $417.82. The company has a market cap of $13.80 billion, a PE ratio of 13.49, a price-to-earnings-growth ...

We recently published a list of 10 Best Healthcare Stocks For Long-Term Investment. In this article, we are going to take a look at where United Therapeutics Corporation (NASDAQ:UTHR) stands against ...

Viking Therapeutics' stock declined by 37% following a downgrade to "hold" in December, anticipating competitive pressures from Novo Nordisk's CagriSema Phase 3 results. The company's GIP/GLP-1 ...

Knight Therapeutics Inc. GUD-T has signed a deal to buy the assets of Paladin Pharma Inc. as the Canadian drug company looks to build out its domestic business after a strategic push into South ...

Three months after an FDA approval for cancer immunotherapy Unloxcyt, Checkpoint Therapeutics has found a buyer. Sun Pharma has agreed to purchase the Massachusetts biotech for an upfront value of ...

Manchester United will return to the US for pre-season preparations this July and August, as part of the Premier League’s Summer Series. The announcement of United’s participation in the ...

If you’ve had to cancel or change a United Airlines flight or have experienced any United operational issues, you’ve likely received a United travel credit. United Airlines issues two types of ...